Refers to the effects on cognition and behavior of antipsychotic drugs that reduce confusion, delusions, hallucinations, and psychomotor agitation in patients with psychoses.
An older term for the first antipsychotic medications, such as chlorpromazine, which produced notable psychomotor retardation, apathy, and emotional detachment. With the introduction of newer atypical antipsychotic drugs with less propensity to cause these side effects, the term became outdated as a general synonym for antipsychotic, although it is still used to refer to the older conventional antipsychotics.
A psychoactive drug that reduces psychotic symptoms but produces some side effects resembling neurological diseases.
Effects on cognition and behavior of antipsychotic drugs, which produce a state of apathy, lack of initiative and limited range of emotion.
An antipsychotic drug which calms a person and stops him or her from worrying, e.g. chlorpromazine hydrochloride.
A term frequently used to describe antipsychotic drugs, referring to the tendency of these drugs to produce a behavioral syndrome of apathy, sedation, decreased initiative, and decreased responsiveness.
Drug that produces neurolepsis.
Category of pharmacological agents that treat psychotic symptoms by reducing the amount of dopamine in the brain.
Drugs used to quieten disturbed patients, whether this is the result of brain damage, mania, delirium, agitated depression or an acute behavioural disturbance. They relieve the florid psychotic symptoms such as hallucinations and thought-disorder in schizophrenia and prevent relapse of this disorder when it is in remission.
Any drug that modifies or treats psychotic behaviors, usually by blocking dopamine receptors in the brain. Examples include haloperidol (a butyrophenone), thorazine (a phenothiazine), and clozapine (a tricylic dibenzodiazepine).
An alternate designation for traditional antipsychotic medications, like haloperidol, which excludes the more contemporary atypical agents such as clozapine (Clozaril).